[The effect and mechanism of SU11248 on proliferation of nasopharyngeal carcinoma cell line CNE-2].
To investigate the effect of sunitinib malate (SU11284) on proliferation of nasopharyngeal carcinoma cell line CNE-2 and explore its mechanism. Nasopharyngeal carcinoma cell line CNE-2 was treated with SU11248 in vitro, and the change in the proliferation of CNE-2 cell line was observed by MTT assay; Real-time fluorescence quantitative PCR (FQ-PCR) and Western blotting were used to detect the levels of P27(KIP1);, cyclin G1 mRNA and protein in CNE-2 cells after treated with 2.5 μg/mL SU11284 for different durations. SU11248 inhibited the proliferation of CNE-2 cells in a concentration- and time-dependent manner. The 50% inhibiting concentration (IC50) was 2.5 μg/mL. Moreover, SU11248 treatment concentration-dependently decreased cyclin G1 mRNA and protein expressions (P<0.05), in contrast, it time-dependently increased P27(KIP1); mRNA and protein levels (P<0.05). SU11248 may significantly inhibit the proliferation of CNE-2 cells through up-regulating P27(KIP1); and down-regulating cyclin G1.